Twist Bioscience Corporation

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various academic research applications. Its portfolio includes Oligo pools for targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, and data storage in DNA. It also provides immunoglobulin G proteins for drug discovery, NGS tools such as library preparation kits and human exome kits, and methylation detection kits for cancer and rare disease study. Additionally, Twist offers synthetic SARS-CoV-2 RNA reference sequences, monkeypox controls, and respiratory viral controls for influenzas, RSV, rhinoviruses, SARS, MERS, and coronaviruses, as well as research panels like the Twist Respiratory Virus Panel and Pan-Viral Research Panel.

Twist Bioscience Corporation is listed on the Nasdaq Global Select Market (NasdaqGS) under the ticker symbol TWST. The trading currency for its shares is the US Dollar (USD). As a US-based company, its stock is traded in the United States, and investors typically use USD to buy and sell shares on the Nasdaq exchange.

Twist Bioscience Corporation operates in the Healthcare sector and is classified under the Diagnostics & Research industry. This means the company is involved in developing and providing diagnostic tools and research products, specifically focusing on synthetic DNA-based solutions. Its products support a wide range of applications, from drug discovery and development to genetic testing and infectious disease research, making it a key player in the healthcare and life sciences research space.

Twist Bioscience Corporation offers a diverse portfolio of synthetic DNA-based products and services. Key offerings include synthetic genes and gene fragments for product development in therapeutics, diagnostics, and industrial applications. The company provides Oligo pools for targeted next-generation sequencing (NGS), CRISPR gene editing, and DNA data storage. It also supplies NGS tools such as library preparation kits, human exome kits, and custom panels for diagnostic tests and research. Additionally, Twist offers methylation detection kits for cancer and rare disease studies, and synthetic controls for infectious diseases including SARS-CoV-2, monkeypox, and various respiratory viruses. Its research panels, like the Twist Respiratory Virus Panel, support comprehensive viral research.

Twist Bioscience Corporation serves a broad range of customers, including biotechnology and pharmaceutical companies, industrial chemical and agricultural firms, and academic research laboratories. Its synthetic DNA products are used by these customers for applications such as drug discovery and development, diagnostic test development, and fundamental research in fields like genetics and molecular biology. The company's NGS tools and synthetic controls also cater to clinical diagnostics and infectious disease research, supporting both commercial and academic entities in advancing their scientific and medical endeavors.